AVENIO Trademark

Trademark Overview


On Wednesday, April 13, 2022, a trademark application was filed for AVENIO with the United States Patent and Trademark Office. The USPTO has given the AVENIO trademark a serial number of 97360897. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 1, 2024. This trademark is owned by Roche Molecular Systems, Inc.. The AVENIO trademark is filed in the Pharmaceutical Products category with the following description:

In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
avenio

General Information


Serial Number97360897
Word MarkAVENIO
Filing DateWednesday, April 13, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Goods and ServicesIn vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events


Event DateEvent Description
Saturday, April 16, 2022NEW APPLICATION ENTERED
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 30, 2023ASSIGNED TO EXAMINER
Monday, January 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 1, 2024SOU EXTENSION 2 FILED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023SOU EXTENSION 1 GRANTED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 1, 2024SOU EXTENSION 2 GRANTED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED